Bessemer Group
IMGN

Bessemer Group’s Immunogen Inc IMGN Stock Holding History

Bessemer Group’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-16,678
Closed -$65K – 1934
2017
Q1 		$65K Buy
+16,678
New +$48.7K ﹤0.01% 1261
2016
Q3 		– Sell
-2,130
Closed -$7K – 1888
2016
Q2 		$7K Sell
2,130
-320
-13% -$2.01K ﹤0.01% 1132
2016
Q1 		$21K Buy
2,450
+2,103
+606% +$17.8K ﹤0.01% 1057
2015
Q4 		$5K Buy
+347
New +$4.27K ﹤0.01% 1384
2014
Q3 		– Sell
-290
Closed -$3K – 1419
2014
Q2 		$3K Sell
290
-753
-72% -$9.45K ﹤0.01% 1238
2014
Q1 		$16K Buy
+1,043
New +$16.4K ﹤0.01% 1025
2013
Q4 		– Sell
-100
Closed -$2K – 1400
2013
Q3 		$2K Buy
+100
New +$1.76K ﹤0.01% 1212

Other funds holding IMGN

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Bessemer Group's IMGN Position: Q2 2017 in Review

Bessemer Group sold out of Immunogen Inc (IMGN) in Q2 2017, closing a stake of 16,678 shares — an estimated $65K sold.

Bessemer Group first reported a position in IMGN in Q3 2013 and held it in 7 quarters. The position peaked at $65K in Q1 2017. 157 funds tracked by Wall St. Rank hold IMGN as of Q2 2017.

  • Bessemer Group reported no remaining Immunogen Inc position as of Q2 2017 after selling out during the quarter.
  • Bessemer Group sold 16,678 Immunogen Inc shares in Q2 2017, an estimated $65K.
  • Bessemer Group first reported a position in Immunogen Inc in Q3 2013 and held it in 7 quarters.
  • Bessemer Group's Immunogen Inc position peaked at $65K in Q1 2017.
  • 157 funds tracked by Wall St. Rank held Immunogen Inc as of Q2 2017.

Based on Bessemer Group's 13F filing for Q2 2017, filed 28 Jul 2017.